浙江省宁波市登革热疾病经济负担研究

doi:10.11853/j.issn.1003.8280.2020.04.001

摘要
图/表
参考文献(0)
相关文章 (15)

全文: PDF (459 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要

目的评估2018年宁波市登革热疾病经济负担，为卫生行政部门制定相关防控策略提供一定的量化依据。方法选取在宁波市某三级甲等医院住院隔离治疗的40例登革热新发病例为研究对象，通过回顾性研究，收集病例就医经过、治疗费用、间接费用、医保报销比例等信息，估算登革热病例的经济负担。结果 40例病例住院天数的中位数为8（6~9）d；人均登革热疾病经济负担为3 718.16（2 453.19~5 536.46）元，其中直接疾病经济负担为2 253.75（767.16~3 606.54）元，间接疾病经济负担为1 701.36（1 432.72~1 813.29）元，直接疾病经济负担占疾病经济负担中较大的比重。总体经济负担约为26.03（17.17~38.76）万元，其中直接疾病经济负担为15.78万元，间接疾病经济负担为11.91万元。40例登革热病例的医保参保率为72.50%，直接医疗经济负担、直接疾病经济负担和疾病经济负担与医疗保险报销比例存在负相关，医保报销比例越高，直接医疗经济负担越低（P<0.05）。结论宁波市登革热疾病经济负担较高，应进一步提高医疗保险的参保率，降低患者的直接医疗经济负担。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	陈奕
	易波
	劳旭影
	董莹
	丁克琴
	张栋梁
	许国章

关键词 ：登革热, 疾病经济负担, 医保参保率

Abstract：

Objective To assess the economic burden of dengue fever in Ningbo, Zhejiang province, China, 2018, and to provide a certain quantitative basis for the health administrative institution to formulate relevant prevention and control strategies. Methods Forty new cases of dengue fever were selected who were isolated and treated in a grade A tertiary hospital of Ningbo. Their information such as hospitalization process, treatment costs, indirect costs, and medical insurance reimbursement rate were collected to estimate the economic burden of dengue fever. Results The median length of hospitalization of the 40 cases was 8 (6-9) days. The economic burden of dengue fever was 3 718.16 (2 453.19-5 536.46) yuan per capita, with the direct economic burden of disease of 2 253.75 (767.16-3 606.54) yuan and the indirect economic burden of disease of 1 701.36 (1 432.72-1 813.29) yuan, indicating that the direct economic burden accounted for a large proportion. The total economic burden was about 260.30 (171.70-387.60) thousand yuan, with the direct economic burden of disease of 157.8 thousand yuan and the indirect economic burden of disease of 119.10 thousand yuan. Of the 40 dengue fever cases, 72.50% participated in medical insurance. The medical insurance reimbursement rate was negatively correlated with the direct medical economic burden, the direct economic burden of disease, and the economic burden of disease; the direct medical economic burden decreased as the reimbursement rate increased (P<0.05). Conclusion The economic burden of dengue fever in Ningbo is relatively high, the participation rate in medical insurance should be further increased to reduce the direct medical economic burden of patients.

Key words： Dengue fever Economic burden of disease Medical insurance participation rate

收稿日期: 2020-03-24

PACS:

R373.3+3

基金资助:

浙江省基础公益研究计划项目（LGF20H260007）；浙江省科技计划项目（2019C35102）；宁波市医疗卫生品牌学科（PPXK2018-10）

通讯作者: 许国章,Email:xugz@nbcdc.org.cn E-mail: xugz@nbcdc.org.cn

作者简介: 陈奕,女,硕士,副主任医师,主要从事急性传染病控制工作,Email:30279068@qq.org.cn

引用本文:

陈奕, 易波, 劳旭影, 董莹, 丁克琴, 张栋梁, 许国章. 浙江省宁波市登革热疾病经济负担研究[J]. 中国媒介生物学及控制杂志, 2020, 31(4): 385-388. CHEN Yi, YI Bo, LAO Xu-ying, DONG Ying, DING Ke-qin, ZHANG Dong-liang, XU Guo-zhang. A study of economic burden of dengue fever in Ningbo, Zhejiang province, China. Chines Journal of Vector Biology and Control, 2020, 31(4): 385-388.

链接本文:

http://www.bmsw.net.cn/CN/10.11853/j.issn.1003.8280.2020.04.001 或 http://www.bmsw.net.cn/CN/Y2020/V31/I4/385

[1] Shepard DS,Undurraga EA,Halasa YA,et al. The global economic burden of dengue:a systematic analysis[J]. Lancet Infect Dis,2016,16(8):935-941. DOI:10.1016/S1473-3099(16)00146-8.
[2] Guo CC,Zhou ZX,Wen ZH,et al. Global epidemiology of dengue outbreaks in 1990-2015:a systematic review and meta-analysis[J]. Front Cell Infect Microbiol,2017,7:317. DOI:10.3389/fcimb.2017.00317.
[3] Pathak VK,Mohan M. A notorious vector-borne disease:Dengue fever,its evolution as public health threat[J]. J Family Med Prim Care,2019,8(10):3125-3129. DOI:10.4103/jfmpc.jfmpc_716_19.
[4] 孟凤霞,王义冠,冯磊,等. 我国登革热疫情防控与媒介伊蚊的综合治理[J]. 中国媒介生物学及控制杂志,2015,26(1):4-10. DOI:10.11853/j.issn.1003.4692.2015.01.002. Meng FX,Wang YG,Feng L,et al. Review on dengue prevention and control and integrated mosquito management in China[J]. Chin J Vector Biol Control,2015,26(1):4-10. DOI:10.11853/j.issn.1003.4692.2015.01.002.
[5] 宁文艳,鲁亮,任红艳,等. 2004-2013年间中国登革热疫情时空变化分析[J]. 地球信息科学学报,2015,17(5):614-621. DOI:10.3724/SP.J.1047.2015.00614. Ning WY,Lu L,Ren HY,et al. Spatial and temporal variations of dengue fever epidemics in China from 2004 to 2013[J]. J Geo-Inform Sci,2015,17(5):614-621. DOI:10.3724/SP.J.1047.2015.00614.
[6] 刘振江,吴春敏,叶素贞,等. 福建北部首次登革热暴发疫情分子流行病学研究[J]. 中国病毒病杂志,2016,6(1):54-58. Liu ZJ,Wu CM,Ye SZ,et al. Molecular epidemiology of first dengue fever outbreak in Nanping,Fujian province of China[J]. Chin J Viral Dis,2016,6(1):54-58.
[7] 范建华,冯云,朱进,等. 2017年云南省西双版纳州登革1型病毒暴发疫情的调查研究[J]. 疾病监测,2019,34(5):427-434. DOI:10.3784/j.issn.1003-9961.2019.05.013. Fan JH,Feng Y,Zhu J,et al. An outbreak of dengue serotype 1 virus in Xishuangbanna prefecture of Yunnan province,China,2017[J]. Dis Surveill,2019,34(5):427-434. DOI:10.3784/j.issn.1003-9961.2019.05.013.
[8] 杜燕华,张白帆,李懿,等. 河南省登革热1型病毒的发现与全基因组序列分析[J]. 中华预防医学杂志,2015,49(10):892-895. DOI:10.3760/cma.j.issn.0253-9624.2015.10.011. Du YH,Zhang BF,Li Y,et al. Discovery and whole genome sequences analysis of a dengue virus type 1 strain isolated in Henan province[J]. Chin J Prev Med,2015,49(10):892-895. DOI:10.3760/cma.j.issn.0253-9624.2015.10.011.
[9] 田丽丽,吕颖,林晖,等. 2006-2016年北京市登革热时空分布特征[J]. 寄生虫与医学昆虫学报,2017,24(4):224-229. DOI:10.3969/j.issn.1005-0507.2017.04.004. Tian LL,Lyu Y,Lin H,et al. Temporal and spatial distribution characteristics analysis of dengue fever from 2006 to 2016 in Beijing[J]. Acta Parasitol Med Entomol Sin,2017,24(4):224-229. DOI:10.3969/j.issn.1005-0507.2017.04.004.
[10] 宗春辉,赵辉,彭健. 泰安归国劳务人员中首次检出登革热病例[J]. 口岸卫生控制,2018,23(2):55-56. DOI:10.3969/j.issn.1008-5777.2018.02.017. Zong CH,Zhao H,Peng J. The first detected dengue fever in returned laborers in Tai'an[J]. Port Health Control,2018,23(2):55-56. DOI:10.3969/j.issn.1008-5777.2018.02.017.
[11] Hung TM,Wills B,Clapham HE,et al. The uncertainty surrounding the burden of post-acute consequences of dengue infection[J]. Trends Parasitol,2019,35(9):673-676. DOI:10.1016/j.pt.2019.06.004.
[12] Carolina TD,Undurraga EA,Ramos-Castañeda J,et al. Persistent symptoms of dengue:estimates of the incremental disease and economic burden in Mexico[J]. Am J Trop Med Hyg,2016,94(5):1085-1089. DOI:10.4269/ajtmh.15-0896.
[13] Supadmi W,Suwantika AA,Perwitasari DA,et al. Economic evaluations of dengue vaccination in the southeast Asia region:evidence from a systematic review[J]. Value Health Reg Issues,2019,18:132-144. DOI:10.1016/j.vhri.2019.02.004.
[14] Shepard DS,Undurraga EA,Lees RS,et al. Use of multiple data sources to estimate the economic cost of dengue illness in Malaysia[J]. Am J Trop Med Hyg,2012,87(5):796-805. DOI:10.4269/ajtmh.2012.12-0019.
[15] Suaya JA,Shepard DS,Chang MS,et al. Cost effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti[J]. Trop Med Int Health,2007,12(9):1026-1036. DOI:10.1111/j.1365-3156.2007.01889.x.
[16] Shepard DS,Undurraga EA,Halasa YA. Economic and disease burden of dengue in Southeast Asia[J]. PLoS Negl Trop Dis,2013,7(2):e2055. DOI:10.1371/journal.pntd.0002055.
[17] Lee JS,Mogasale V,Lim JK,et al. A multi-country study of the economic burden of dengue fever:Vietnam,Thailand,and Colombia[J]. PLoS Negl Trop Dis,2017,11(10):e0006037. DOI:10.1371/journal.pntd.0006037.